Ongoing shortages of common oncology chemotherapies have compelled physicians to substitute more expensive drugs, delay or suspend clinical trials, or even skip doses of chemotherapy, according to survey results presented at ASCO.
Mary Caffrey for AJMC.com
Advertisement
Articles by Mary Caffrey for AJMC.com
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Accepts NDA for AD109 for Treatment of Adults With Obstructive Sleep Apnea
2
Men Face Higher Odds of Later-Stage Diagnosis Across 20 Cancer Types
3
Clinical Forum Events Highlight the Evolving Landscape of Obesity Management
4
Workforce Preparation for Fall Immunization Season Starts Now
5